Partnering with pharmaceutical and biotechnology firms is a key component of our business strategy. In some cases, we will partner at a very early stage by means of research collaborations, and in other cases we will develop compounds on our own and commence clinical trials before seeking a development and/or commercialization partners.

At DURECT, we understand the complexity and challenges pharmaceutical companies face in bringing new drugs to market. We also understand that risk is inherent throughout the development and approval process. And we believe we can help companies manage and minimize this risk through unique partnering relationships. In addition, our delivery platforms may help extend the proprietary positions of your drug franchises and enable new claims with novel dosage forms.

At DURECT, we offer a broad range of innovative drug delivery systems that are an essential element to any new controlled-release drug product. We offer sustained release technology platforms that provide delivery of your product from days to years based on your therapeutic and business needs. Many, but not all, of these technology options can be found here on our website. Our dedicated team of scientists and formulators offer additional expertise to custom-tailor drug delivery to our client’s needs, whether parenteral, oral, transdermal, local or topical. It is this experience and expertise that accelerate the product development timelines, reduce development risk and increase the probability for a successful outcome.